Nature | Vol 577 | 2 January 2020 | 129that had abundances ranging between 30 and 75%, including several
isoforms of HSP90 and six HSP70 isoforms (Fig. 2a; see Supplementary
Information for details).
NMR spectroscopy in cells
Next, we carried out NMR experiments in cells to study the interaction
between α-synuclein and chaperones inside living mammalian cells
at atomic resolution. [U-^15 N]-α-Synuclein was delivered into HEK293
cells at concentrations of 3–10 μM, yielding intensity patterns that are
characteristic for mammalian cell lines^9 (Fig. 2b, c), such as the canoni-
cal chaperone-interaction signature. Multiple molecular chaperones
are present in the cell that have mutually overlapping functions and
‘clientomes’^20. To complement the in vitro chaperone analyses, we
investigated two of the most abundant chaperones found in mammalian
cells, HSC70 and HSP90β. When [U-^15 N]-α-synuclein was delivered into
HEK293 cells with reduced HSC70 levels (Extended Data Fig. 7c, d), the
NMR intensity profile resembled the one observed for untreated cells,
suggesting that there is functional redundancy between HSC70 and
other chaperones in these cells (Fig. 2d, e). Next, we treated HEK293IHEK/I bufferI/IHEKI/IHEKI/IHEKI/IHEK1.20.40.80.81.20.41.52.01.0
0.520 40 60 80 100 120 140
α-Synuclein residue numberα-Synuclein residue numberHSC70-depleted HEK293 cellsHEK293 cells + 24 h HSP90 inhibitorsHSC70-depleted HEK293 cells + 24 h HSP90 inhibitorsHSP90`
HSP90α
HSP60HSP90 family HSP70 family HSP60 family 14-3-3 familyCCTb
CCTe
CCTε
CCTβ
CCTζ
CCTγ
CCTα
HSP105 14-3-3γ14-3-3ζ/δ
14-3-3εCyclophilin A14-3-3θ
14-3-3β/α
HSP701A
HSP704
HSC70 GRP-78GRP-75
EndoplasmindaΔN-α-Synuclein/α-synuclein00.40.800.20.40.60.81.0G86 G31G93
T92T81D121E130E110E83
K96 L38
A89L113
A27
A53N103Q109V95V15V48V77
V118
D115K12Y39Y136V37A107δ 2 (^1 H) (ppm)δ 2 (^1 H) (ppm)8.50 8.25 8.00110115120125130δ^1(^15) (
N) (ppm)
δ^1
(^15) (
N) (ppm)
HEK293 cells
fHSC70-depleted HEK293 cells + 24 h HSP90 inhibitors
8.50 8.25 8.00
HEK293 cells
e HSC70-depleted HEK293 cells
0
0.8
1.2
0.4
G51 G41
G31
M5
D2
D121
A124
A17
E137
A140
E126
V40
D119
S129 S9
N122
E130H50
AcM1
K6
K21 F4
D135 L8
V3
8.50 8.25 8.00
In vitro
HEK293 cells
b
c
20 40 60 80 100 120 140
110
115
120
125
130
HSC70-depleted HEK293 cells + 4 h HSP90 inhibitors
Fig. 2 | The interaction between α-synuclein and chaperones is dominant in
living cells. a, Abundance ratios of proteins bound to ΔN-α-synuclein versus
wild-type full-length α-synuclein determined by relative quantitative mass
spectrometry (mean values, n = 2). b, Overlay of two-dimensional [^15 N, ^1 H]-NMR
spectra of [U-^15 N]-α-synuclein in NMR buffer (black) and inside living HEK293
cells (blue-green). Representative spectrum from n > 5. c, Residue-resolved
backbone amide NMR signal attenuation (IHEK/Ibuffer) of α-synuclein in
mammalian cells. d, NMR signal attenuation in treated cells, relative to
untreated cells (I/IHEK). Different combinations of HSC70 depletion and HSP90
inhibition were applied, as indicated. e, f, Overlay of two-dimensional [^15 N, ^1 H]-
NMR spectra of [U-^15 N]-α-synuclein in untreated HEK293 cells (black) and in
HSC70-depleted HEK293 cells (green) (e) or in HSC70-depleted HEK293 cells
after 24 h of HSP90 inhibition (green) (f). Representative data (d–f) for three
technical replicates, with similar results.